Search Within

Sandra Pierina D'Angelo

Formats
  1. Meeting Abstract (136)
  2. Journal Article (104)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (252)
  2. Hematologic Malignancies, Division of (252)
  3. Sarcoma Service (252)
  4. Solid Tumor Oncology Division (252)
  5. GSK Faculty (101)
  6. Tow Center for Developmental Oncology (TCDO) (88)

More Groups

People
  1. William Tap (104)
  2. Mark Dickson (83)
  3. Mrinal Gounder (72)
  4. Mary Keohan (70)
  5. Ping Chi (58)
  6. Cristina Antonescu (53)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Journal for ImmunoTherapy of Cancer (22)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (103)
  2. Biomed Central Ltd (24)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (252)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Journal Article

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Dickson, M.; Gounder, M.; Keohan, M. L.; Chi, P.; Kelly, C.; Movva, S.; Nacev, B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour
    Journal Article

    Cassier, P. A.; Italiano, A.; Gomez-Roca, C.; Le Tourneau, C.; Toulmonde, M.; D'Angelo, S. P.; Weber, K.; Loirat, D.; Jacob, W.; Jegg, A. M.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts
    Meeting Abstract

    Chen, J. L.; Mahoney, M. R.; George, S.; Antonescu, C. R.; Liebner, D. A.; Van Tine, B. A.; Milhem, M. M.; Tap, W. D.; Streicher, H.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
    Meeting Abstract

    Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab
    Journal Article

    Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; more...
    Future Oncology (2020)

    Fulltext@MSK | Save
  • Patient experiences with avelumab in treatment-naïve metastatic Merkel cell carcinoma: Longitudinal qualitative interview findings from JAVELIN Merkel 200, a registrational clinical trial
    Journal Article

    Lambert, J.; Marrel, A.; D’Angelo, S. P.; Burgess, M. A.; Chmielowski, B.; Fazio, N.; Gambichler, T.; Grob, J. J.; Lebbé, C.; Robert, C.; more...
    The Patient: Patient-Centered Outcomes Research (2020)

    Fulltext@MSK | Save
  • Comparing patient-relevant endpoint with clinical endpoint in a rare disease: The case of metastatic Merkel cell carcinoma treated with avelumab
    Meeting Abstract

    Bharmal, M.; Nolte, S.; Lebbe, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; more...
    Value in Health (2020)

    Fulltext@MSK | Save